The subsidiary of Taiji Group (600129.SH), Yansuan Tuomoxitin Capsule, has obtained a drug registration certificate.

Chinavision Financial News APP News, Taiji Group (600129.SH) announced that recently, the company's controlling subsidiary, Southwest Pharmaceutical Co., Ltd., has received the "Drug Registration Certificate" for Timosetine Hydrochloride Capsules issued by the National Medical Products Administration. This drug is suitable for treating attention deficit/hyperactivity disorder (ADHD) in children and adolescents.